CompletedPhase 2NCT00328874

Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy

Studying Classic progressive supranuclear palsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
German Parkinson Study Group (GPS)
Principal Investigator
Wolfgang Oertel, Professor
Neurologische Klinik der Philipps Universität Marburg
Intervention
Coenzyme Q10(drug)
Enrollment
20 enrolled
Eligibility
40-85 years · All sexes
Timeline
20062007

Study locations (1)

Collaborators

MSE Pharmazeutika GmbH, Louisenstr.114D-61348 Bad Homburg, Germany · Pitzer Stiftung · Philipps University Marburg

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00328874 on ClinicalTrials.gov

Other trials for Classic progressive supranuclear palsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Classic progressive supranuclear palsy syndrome

← Back to all trials